UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:April 24,
AcelRX Pharmaceuticals (NASDAQ:ACRX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more AcelRX Pharmaceuticals Charts.
AcelRX Pharmaceuticals (NASDAQ:ACRX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more AcelRX Pharmaceuticals Charts.

Acelrx Pharmaceuticals Inc News

Form ARS - Annual Report to Security Holders
Tuesday 30 April 2024 (3 weeks ago) • Edgar (US Regulatory)
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 30 April 2024 (3 weeks ago) • Edgar (US Regulatory)
Form DEF 14A - Other definitive proxy statements
Tuesday 30 April 2024 (3 weeks ago) • Edgar (US Regulatory)
Form 8-K - Current report
Saturday 20 April 2024 (1 month ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 16 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 10 January 2024 (4 months ago) • Edgar (US Regulatory)
AcelRx Announces Rebranding With Name Change to Talphera, Inc.
Wednesday 10 January 2024 (4 months ago) • PR Newswire (US)
Form 4 - Statement of changes in beneficial ownership of securities
Friday 15 December 2023 (5 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 14 December 2023 (5 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 14 December 2023 (5 months ago) • Edgar (US Regulatory)

More Acelrx Pharmaceuticals Inc News Articles